Invicta Diagnostic shareholders and shareholding pattern
NSE: INVICTAHealthcare Services
Invicta Diagnostic Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2025 · Issue price ₹85
Last close ₹65.00down ₹1.50 (2.26%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹66.50.
28 Oct: open ₹65.00, high ₹65.00, low ₹65.00
Range of traded prices from listing on 8 Dec 2025 to 28 Oct 2026
₹58.10Low, 5 Mar 2026₹105.00High, 8 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹82 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 9.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,200100.0% delivered
Invicta Diagnostic's shareholding pattern for Sep 2026, filed on 9 Oct 2026, with every filing from Mar 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Invicta Diagnostic, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters66.70%
- Foreign institutions1.54%
- Indian institutions4.25%
- Individuals and others27.52%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Mar 2026 | Sep 2026 |
|---|---|---|
| 66.70% | 66.70% | |
| Indian promoters | 66.70% | 66.70% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 33.30% | 33.30% |
| Shares in issue | 1,25,71,973 | 1,25,71,973 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 92,63,173 | 92,63,173 |
| Promoters' shares locked in | 83,84,920 | 83,84,920 |
A dash is a line the filing did not state.
Invicta Diagnostic promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is BADAL KAILASH NAREDI, 11.07%. The filing names 41 more members with no shares.
| Holder | |||
|---|---|---|---|
| BADAL KAILASH NAREDIIndividuals and Hindu undivided families | 11.07% | 13,92,320 | 100.00% |
| ROHIT PRAKASH SRIVASTAVAIndividuals and Hindu undivided families | 11.07% | 13,91,488 | 100.00% |
| SANKET VINOD JAINIndividuals and Hindu undivided families | 10.47% | 13,15,712 | 100.00% |
| JAYESH PRAKASH JAINIndividuals and Hindu undivided families | 7.93% | 9,97,504 | 100.00% |
| MONAL KETAN JAINIndividuals and Hindu undivided families | 7.17% | 9,00,952 | 100.00% |
| DIPIKA JAYANTILAL JAINIndividuals and Hindu undivided families | 4.76% | 5,98,024 | 100.00% |
| AMOL PURUSHOTTAM KHANDELWALIndividuals and Hindu undivided families | 4.03% | 5,06,752 | 100.00% |
| KUSHAL WAYUNANDAN KOLIIndividuals and Hindu undivided families | 2.15% | 2,70,208 | 100.00% |
| KUNAL ANIL JAINIndividuals and Hindu undivided families | 1.69% | 2,12,160 | 100.00% |
| GHISULAL MANGILAL PARMARIndividuals and Hindu undivided families | 1.54% | 1,93,824 | 100.00% |
| KETAN JAYANTILAL JAINIndividuals and Hindu undivided families | 1.54% | 1,93,600 | 100.00% |
| VIDHI SHRAMIK RATHOREIndividuals and Hindu undivided families | 1.39% | 1,74,272 | 100.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Invicta Diagnostic, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2026 | Sep 2026 |
|---|---|---|
| NIHAR AMIT DAVEResident individuals, over ₹2 lakh at face value | 2.38% | 3.46% |
| SHINE STAR BUILD CAP PVT LTDCompanies | 3.22% | 3.22% |
| RGSL INVESTMENT FUND - RGSL INVESTMENT LVF 1Alternative investment funds | 1.64% | 1.62% |
| BIRCHWOOD MULTI STRATEGY FUND OPEN ENDED PCC LIMITED-BIRCHWOOD GLOBAL ALPHA FUNDForeign portfolio investors, category I | – | 1.54% |
| AVORA SME FUND 1Alternative investment funds | 1.16% | 1.13% |
| MANISH GROVERResident individuals, over ₹2 lakh at face value | 1.01% | 1.01% |
| PINE OAK GLOBAL FUNDForeign portfolio investors, category I | 2.72% | – |
| INVESTI GLOBAL OPPORTUNITY FUND PCC - CELL 1Foreign portfolio investors, category I | 1.02% | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Mar 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: PINE OAK GLOBAL FUND no longer named, from 2.72%; BIRCHWOOD MULTI STRATEGY FUND OPEN ENDED PCC LIMITED-BIRCHWOOD GLOBAL ALPHA FUND newly named at 1.54%; INVESTI GLOBAL OPPORTUNITY FUND PCC - CELL 1 no longer named, from 1.02%
- Indian institutions: AVORA SME FUND 1 1.13%, −0.03 pts; RGSL INVESTMENT FUND - RGSL INVESTMENT LVF 1 1.62%, −0.02 pts
- Individuals and others: NIHAR AMIT DAVE 3.46%, +1.08 pts